MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Partnering with Community Through Co-designed Education for People Living with Parkinson’s

    R. Mouer, V. Mcconvey (Camberwell, Australia)

    Objective: To provide people with Parkinson’s opportunities to be involved in the creation and delivery of education related to their condition, and to empower community…
  • 2026 International Congress

    The 360° Turn Test as a Single and Dual Task in people with Parkinson’s disease and cognitively unimpaired controls

    M. Lindh-Rengifo, S. Fors, S. Palmqvist, E. Stomrud, N. Mattsson-Carlgren, M. Nilsson (Lund, Sweden)

    Objective: To investigate the effects of adding a cognitive subtraction task on the duration of the 360° turn test, and to compare the performance between…
  • 2026 International Congress

    Experiences with Adaptive Deep Brain Stimulation for Parkinson’s Disease in Routine Clinical Care

    SS. Vegelin, A. Oswal, D. Ledingham, M. Janssen, A. Querejeta-Coma, K. Balagula, C. Oehrn, A. Macerollo, M. Contarino, G. Oyama, T. Herrington, A. Fasano, B. De-La Casa-Fages, B. Swinnen, G. Tinkhauser, C. Gonzales-Robles, R. Jech, I. Avilés-Olmos, M. Beudel, IAD. Registry Consortium (Amsterdam, Netherlands)

    Objective: To evaluate initial experiences and (symptom-specific) outcomes with adaptive deep brain stimulation (aDBS) for Parkinson’s disease (PD) in routine clinical care across multiple international…
  • 2026 International Congress

    Evaluating the Conversion of Immediate-Release and/or Extended-Release Levodopa to IPX203 in Patients with Parkinson’s Disease

    L. Poon, A. Lee, D. Lee, T. Chiao, T. Stiep (San Francisco, USA)

    Objective: This quality improvement (QI) project was conducted to evaluate the impact of the conversion from immediate-release (IR) and/or extended-release (ER) levodopa (LD) to mucoadhesive polymer…
  • 2026 International Congress

    Longitudinal evolution of impulsive-compulsive behaviors and their prognostic value in Parkinson’s disease

    M. Rocha-de-León, A. Beltrán-Torres, N. Sánchez-Lorenzo, K. Sánchez-Ramírez, D. Nafate-Wences, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To characterize longitudinal trajectories of impulsive-compulsive behaviors (ICD) in PD and to determine their prognostic value for quality of life and dopaminergic medication requirements…
  • 2026 International Congress

    Safety of Opicapone After 10 Years of Post-Marketing experience Worldwide

    M. Vale, D. Lopes, H. Brigas, J. Holenz (Coronado, Portugal)

    Objective: To review the safety data of opicapone (OPC) after 10 years of worldwide marketing experience. Background: OPC, a third-generation COMT inhibitor, is approved as…
  • 2026 International Congress

    Quantitative Analysis of the DESH in Normal Pressure Hydrocephalus and Parkinson’s Disease

    N. Takemura, T. Tsunemi, S. Niiyama, S. Yamada, C. Iseki, Y. Ohta, T. Hatano (Bunkyo-ku, Japan)

    Objective: To investigate whether Parkinson’s disease (PD) exhibits imaging features similar to normal pressure hydrocephalus (NPH) by comparison with healthy controls and NPH patients, and…
  • 2026 International Congress

    Uncovering Sleep Neural Signatures of Parkinson’s Disease and REM Sleep Behavior Disorder from Polysomnography through Interpretable Deep Learning

    S. Kim, J. Jeong, YJ. Jung (Daejoen, Republic of Korea)

    Objective: To uncover sleep physiological signatures that distinguish Parkinson's disease (PD) and REM sleep behavior disorder (RBD) by reverse-engineering what a deep learning classifier learns…
  • 2026 International Congress

    Clinical Relevance of Oral Health Assessment in Parkinson’s Disease Monitoring

    R. Naqvi, V. Ha, S. Elshourbagy, A. Valverde, S. Tomar, J. Schwartz, A. Naqvi, P. Engen, M. Shaikh, C. Neumann, M. Villanueva, D. Sanchez-Bass, L. Dibenedetto, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To evaluate the clinical relevance of oral health assessment in Parkinson’s disease (PD) by determining whether oral inflammatory, microbial, and periodontal alterations are associated…
  • 2026 International Congress

    Synuclein and dopamine transporter biomarkers among phenoconverters to parkinsonian disorders

    C. Simonet, J. Yin, L. Chahine, D. Weintraub, K. Chatterjee, C. Caspell-Garcia, D-E. Lafontant, A. Noyce, T. Simuni (London, United Kingdom)

    Objective: To describe and assess biological congruency, defined as expected biological profile based on abnormal CSF α-synuclein Seed Amplification Assays (CSFaSynSAA) and dopamine transporter SPECT…
  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley